Eric Dobmeier Adaptive Biotechnologies Corp (ADPT) insider trading activity

ADPT Quotes by TradingView

Eric Dobmeier is Director of Adaptive Biotechnologies Corp. Currently has a direct ownership of 1,504 shares of ADPT, which is worth approximately $5,429. The most recent transaction as insider was on Feb 14, 2021, when has been sold 1,504 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.5K
0% 3M change
0% 12M change
Total Value Held $5,429

ERIC DOBMEIER Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 14 2021
BUY
Grant, award, or other acquisition
-
1,504 Added 50.0%
1,504 Common Stock
Jan 04 2021
SELL
Open market or private sale
$580,000 $58.0 p/Share
10,000 Reduced 100.0%
0 Common Stock
Jan 04 2021
BUY
Exercise of conversion of derivative security
$63,200 $6.32 p/Share
10,000 Added 50.0%
10,000 Common Stock
Oct 01 2020
SELL
Open market or private sale
$488,400 $48.84 p/Share
10,000 Reduced 100.0%
0 Common Stock
Oct 01 2020
BUY
Exercise of conversion of derivative security
$63,200 $6.32 p/Share
10,000 Added 50.0%
10,000 Common Stock

Also insider at

KDNY
CHINOOK THERAPEUTICS, INC. Healthcare
President, CEO
ATRA
Atara Biotherapeutics, Inc. Healthcare
GPCR
Structure Therapeutics Inc.
ED

Eric Dobmeier

Director
Seattle, WA

Track Institutional and Insider Activities on ADPT

Follow Adaptive Biotechnologies Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ADPT shares.

Notify only if

Insider Trading

Get notified when an Adaptive Biotechnologies Corp insider buys or sells ADPT shares.

Notify only if

News

Receive news related to Adaptive Biotechnologies Corp

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ADPT